Keyphrases
Neovascular Age-related Macular Degeneration (nAMD)
100%
Diabetic Macular Edema
95%
Visual Acuity
79%
Age-related Macular Degeneration
75%
Spectral Domain Optical Coherence Tomography (SD-OCT)
74%
Optical Coherence Tomography
68%
Intravitreal Ranibizumab
67%
Best-corrected Visual Acuity
65%
Bevacizumab
53%
Retinal Vein Occlusion
47%
Ranibizumab
45%
Faricimab
45%
Israel
41%
Subretinal Fluid
40%
Macular
40%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
39%
Macular Edema
38%
Retina
38%
Intravitreal
36%
Branch Retinal Vein Occlusion
35%
Diabetic Retinopathy
33%
Retinal Thickness
33%
Aflibercept
32%
Myopic Choroidal Neovascularization (mCNV)
28%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
27%
Ozurdex
27%
Dexamethasone Intravitreal Implant
27%
Intravitreal Dexamethasone Implant
27%
Cat Scratch Disease
27%
Susac Syndrome
27%
Visual Outcome
26%
Retinal pigment Epithelium
25%
Ocular Manifestations
25%
Vascular Endothelial Growth Factor
25%
Central Subfield Thickness
25%
Behet's Disease
24%
Proliferative Diabetic Retinopathy
24%
Neuroretinitis
24%
Photoreceptor
23%
Intravitreal Injection
22%
Central Serous Chorioretinopathy
22%
Retinal pigment Epithelial
21%
Retinal Arterial Macroaneurysm
21%
Choroidal Thickness
21%
Treat-and-extend
21%
Rhine
20%
Treatment Duration
19%
Hyperhomocystinemia
19%
Cystoid Macular Edema
19%
Photodynamic Therapy
19%
Medicine and Dentistry
Optical Coherence Tomography
77%
Spectral Domain Optical Coherence Tomography
75%
Visual Acuity
71%
Bevacizumab
55%
Best Corrected Visual Acuity
54%
Wet Macular Degeneration
53%
Age Related Macular Degeneration
52%
Diseases
46%
Dexamethasone
45%
Vasculotropin
42%
Diabetic Retinopathy
40%
Diabetic Macular Edema
37%
Arteritic Anterior Ischemic Optic Neuropathy
36%
Photochemotherapy
34%
Macular Edema
33%
Central Retinal Vein Occlusion
31%
Choroidal Neovascularization
30%
Subretinal Fluid
27%
Retina Vein Occlusion
27%
Cat-Scratch Disease
27%
Retinal Pigment Epithelium
27%
Susac Syndrome
27%
Neuroretinitis
24%
Aflibercept
23%
Branch Retinal Vein Occlusion
23%
Proliferative Diabetic Retinopathy
22%
Intraocular Pressure
22%
Cataract
22%
Prospective Study
21%
Intravitreal Administration
21%
Optic Nerve
21%
Artery Occlusion
20%
Retrospective Study
18%
Photoreceptor
18%
Visual Impairment
18%
COVID-19
18%
Methylenetetrahydrofolate Reductase
18%
Faricimab
18%
Central Retinal Artery Occlusion
18%
Refractive Error
18%
Intravitreal Implant
18%
Nevus
18%
Retinal Detachment
17%
Prevalence
17%
Retinal Nerve Fiber Layer
17%
Vitreous
16%
Diabetes Mellitus
15%
Visual Pigment
15%
Morphology
14%
Ranibizumab
14%